UA97387U - Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis - Google Patents

Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis

Info

Publication number
UA97387U
UA97387U UAU201411061U UAU201411061U UA97387U UA 97387 U UA97387 U UA 97387U UA U201411061 U UAU201411061 U UA U201411061U UA U201411061 U UAU201411061 U UA U201411061U UA 97387 U UA97387 U UA 97387U
Authority
UA
Ukraine
Prior art keywords
patients
prevention
treatment
nephro
causal
Prior art date
Application number
UAU201411061U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Liudmyla Vilenivna Venher
Iryna Vasylivna Yakymenko
Original Assignee
Univ Odesa Nat Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Odesa Nat Medical filed Critical Univ Odesa Nat Medical
Priority to UAU201411061U priority Critical patent/UA97387U/en
Publication of UA97387U publication Critical patent/UA97387U/en

Links

Abstract

Спосіб диференційованої нефрогепатопротекторної терапії та профілактики захворювань нирок, що виникають при проведенні етіотропного протитуберкульозного лікування у хворих на вперше діагностований туберкульоз легень полягає в тому, що в залежності від рівня біохімічних показників крові - мікроальбумінурії, аланін амінотрансферази, аспартатамінотрансферази застосовують нефропротекторні препарати.The method of differentiated nephrohepatoprotective therapy and prevention of kidney diseases arising from the conduct of etiotropic antituberculosis treatment in patients with newly diagnosed pulmonary tuberculosis is that, depending on the level of biopheromic indicators of blood, microalbumin, and microalbumin

UAU201411061U 2014-10-10 2014-10-10 Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis UA97387U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201411061U UA97387U (en) 2014-10-10 2014-10-10 Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201411061U UA97387U (en) 2014-10-10 2014-10-10 Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis

Publications (1)

Publication Number Publication Date
UA97387U true UA97387U (en) 2015-03-10

Family

ID=52990550

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201411061U UA97387U (en) 2014-10-10 2014-10-10 Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis

Country Status (1)

Country Link
UA (1) UA97387U (en)

Similar Documents

Publication Publication Date Title
EA201792642A1 (en) DIAGNOSTIC METHODS FOR T-CELL THERAPY
EA201790398A1 (en) METHODS OF TREATING LIVER DISEASES
MX2016009060A (en) Methods and systems for determining risk of heart failure.
PH12016501809A1 (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
BR112017016952A2 (en) combination therapy with coagulation factors and multispecific antibodies
EA201691314A1 (en) THERAPEUTIC WAYS AND COMPOSITIONS
MX2018004170A (en) Biomarkers related to interleukin-33 (il-33)-mediated diseases and uses thereof.
PH12016502167A1 (en) Hdl theraphy markers
PH12018502593A1 (en) Combinations of linagliptin and metformin
MX2019005401A (en) Methods of treating alport syndrome using bardoxolone methyl or analogs thereof.
BR112017002637A2 (en) methods to treat or prevent eye conditions
MX2018012493A (en) Methods for monitoring and treating cancer.
EA201790444A1 (en) HSP90-directed visualization and inflammation therapy and infection
NZ730664A (en) A method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases
EA201790893A1 (en) METHODS OF TREATMENT OF OPHTHALMOLOGICAL DISORDERS
MX2018002298A (en) Methods of using interleukin-10 for treating diseases and disorders.
MX2017010516A (en) Biomarkers for diagnosis and prognosis of corneal ectatic disorders.
MX2017006491A (en) Compositions and methods for modulating at2r activity.
EA201691335A1 (en) HEXAHYDROFUROPYRROLES AS INHIBITORS PDE1
UA97387U (en) Method for differentiate nephro-hepatoprotective therapy and prevention of kidney disease, which arise in causal tb treatment in patients with newly diagnosed pulmonary tuberculosis
WO2015157655A3 (en) Method for predicting response to vegf targeted therapeutics
UA110302C2 (en) Method of diagnosis of allergic rhinitis, combined with bronchial asthma in children
UA93315U (en) Method for diagnosing failure of union in fracture
UA92857U (en) Method of early detection of dismetabolic disorders and metabolic syndrome x that affect locomotive crews
EA201401218A2 (en) METHOD OF NOSOLOGICAL EXPRESS DIAGNOSTICS